CARLSMED, INC. (CARL) financial statements and ratios from SEC XBRL: revenue $50.51M (TTM), net margin -58.7%, revenue growth 85.9% YoY, P/E 123.3. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $50.51M |
| Net Margin | -58.7% |
| Return on Equity | -43.1% |
| Debt / Equity | 0.18 |
| Current Ratio | 8.84 |
| Revenue Growth (YoY) | 85.9% |
| EPS Growth (YoY) | -65.3% |
| FCF Growth (YoY) | 15.5% |
| P/E Ratio | 123.3 |
| EV / EBITDA | -8.9 |
| Price / Book | 4.39 |
| Price / Sales | 5.85 |
| FCF Yield | -9.3% |
| Altman Z-Score | 8.03 (safe) |
| Sector P/E (Healthcare) | 21.6 |
CARL overview · CARL earnings · CARL KPIs · CARL investor relations · CARL ownership · CARL peers · CARL filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.